| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/A:1018937416447 |
| P698 | PubMed publication ID | 8430047 |
| P2093 | author name string | G M Grass | |
| N Jezyk | |||
| W Rubas | |||
| P2860 | cites work | Assessment of the lactulose-mannitol test in Crohn's disease | Q34529682 |
| Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells | Q34532617 | ||
| Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability | Q34561438 | ||
| Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells | Q35003095 | ||
| The physiological disposition and metabolic fate of hydrocortisone in man. | Q35292505 | ||
| The use of cultured epithelial and endothelial cells for drug transport and metabolism studies | Q37939943 | ||
| Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells | Q41729606 | ||
| Unstirred layer and kinetics of electrogenic glucose absorption in the human jejunum in situ | Q43249502 | ||
| Intestinal permeability and screening tests for coeliac disease | Q43255710 | ||
| Gastrointestinal permeability to polyethylene glycol: an evaluation of urinary recovery of an oral load of polyethylene glycol as a parameter of intestinal permeability in man. | Q43977113 | ||
| In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell. | Q45975383 | ||
| A correlation of permeabilities for passively transported compounds in monkey and rabbit jejunum. | Q46027719 | ||
| Permeability characteristics of various intestinal regions of rabbit, dog, and monkey | Q46441017 | ||
| Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400 | Q47327963 | ||
| Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption | Q47443778 | ||
| Paracellular intestinal absorption of glucose, creatinine, and mannitol in normal animals: relation to body size | Q47444124 | ||
| Active hexose transport across cultured human Caco-2 cells: characterisation and influence of culture conditions | Q47572770 | ||
| Nonlinear plasma level response to high doses of naproxen | Q47886452 | ||
| Intestinal glucose transport using perfused rat jejunum in vivo: model analysis and derivation of corrected kinetic constants | Q52536053 | ||
| Intestinal permeability in healthy and allergic children before and after sodium-cromoglycate treatment assessed with different-sized polyethyleneglycols (PEG 400 and PEG 1000). | Q52694141 | ||
| The intestinal unstirred layer: its surface area and effect on active transport kinetics | Q52897969 | ||
| Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus | Q54302286 | ||
| Pharmacokinetics of naproxen in healthy volunteers and in patients with diabetic microangiopathy | Q66985351 | ||
| Determination of thermodynamics of the methylene group in solutions of drug molecules | Q70035738 | ||
| Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability | Q70288908 | ||
| Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease | Q70493470 | ||
| Paracellular absorption of D-glucose by rat small intestine in vivo | Q71051863 | ||
| Passage of molecules through the wall of the gastrointestinal tract. Urinary recovery of different-sized polyethylene glycols after intravenous and intestinal deposition | Q71407892 | ||
| Absorption of steroid hormones from the human small intestine | Q72585065 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 113-118 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption | |
| P478 | volume | 10 |
| Q90195014 | (10Z)-Debromohymenialdisine from Marine Sponge Stylissa sp. Regulates Intestinal Inflammatory Responses in Co-Culture Model of Epithelial Caco-2 Cells and THP-1 Macrophage Cells |
| Q72760478 | A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa |
| Q51609920 | ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties. |
| Q43453290 | An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity |
| Q41154198 | An improved diffusion cell design for determining drug transport parameters across cultured cell monolayers |
| Q33888168 | An integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties. |
| Q44968085 | An integrated method to determine epithelial transport and bioactivity of oral drug candidates in vitro |
| Q87633566 | Analysis of structure-Caco-2 permeability relationships using a property landscape approach |
| Q41986693 | Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls. |
| Q39588990 | Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells |
| Q36266989 | Assessment of the feasibility of oral controlled release in an exploratory development setting |
| Q77749389 | Benzylamine-based selective and orally bioavailable inhibitors of thrombin |
| Q41741827 | Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis. |
| Q33939098 | Caco-2 monolayers in experimental and theoretical predictions of drug transport |
| Q33221011 | Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells |
| Q47280633 | Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds |
| Q41035963 | Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line |
| Q41539834 | Current Concepts in Intestinal Peptide Absorption |
| Q34198854 | Current methodologies used for evaluation of intestinal permeability and absorption |
| Q27682290 | Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation |
| Q73349208 | Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry |
| Q73876559 | Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system |
| Q40495815 | Development of an in vitro co-culture model to mimic the human intestine in healthy and diseased state |
| Q87408588 | Development, validation, and application of a novel 7-day Caco-2 cell culture system |
| Q44225188 | Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers |
| Q45022371 | Effect of folate-binding protein on intestinal transport of folic acid and 5-methyltetrahydrofolate across Caco-2 cells |
| Q73174157 | Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers |
| Q45099519 | Effects of solid dispersion and self-emulsifying formulations on the solubility, dissolution, permeability and pharmacokinetics of isorhamnetin, quercetin and kaempferol in total flavones ofHippophae rhamnoidesL |
| Q53764228 | Establishment and Characterization of a Novel Caco-2 Subclone with a Similar Low Expression Level of Human Carboxylesterase 1 to Human Small Intestine |
| Q40789156 | Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. |
| Q41232588 | Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue |
| Q36830229 | HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans |
| Q41264994 | How structural features influence the biomembrane permeability of peptides |
| Q52687635 | Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption |
| Q74259543 | Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities |
| Q74131061 | Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability |
| Q43446372 | In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system. |
| Q46913799 | In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery |
| Q42978617 | Intestinal absorption mechanisms of ginsenoside Rh2: stereoselectivity and involvement of ABC transporters |
| Q36862858 | Intestinal absorption screening of mixtures from combinatorial libraries in the Caco-2 model |
| Q44260354 | Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat. |
| Q40962903 | Link between drug absorption solubility and permeability measurements in Caco-2 cells |
| Q40983664 | MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening |
| Q41403271 | Mechanism of dextran transport across rabbit intestinal tissue and a human colon cell-line (CACO-2). |
| Q41153253 | Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2. |
| Q73682351 | Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells |
| Q51572321 | Oral Formulations of Adefovir Dipivoxil: In Vitro Dissolution and in Vivo Bioavailability in Dogs |
| Q28397238 | Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern |
| Q41091677 | Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium |
| Q32062298 | P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. |
| Q45945226 | Permeability characteristics of primary cultured rabbit conjunctival epithelial cells to low molecular weight drugs. |
| Q43638506 | Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2. |
| Q37146194 | Permeation of four oral drugs through human intestinal mucosa |
| Q52042689 | Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. |
| Q52238446 | Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure |
| Q34581541 | Prediction of intestinal permeability |
| Q46818266 | Prediction of permeability coefficients of compounds through caco-2 cell monolayer using artificial neural network analysis |
| Q29048210 | Prediction of the permeability of neutral drugs inferred from their solvation properties |
| Q55188486 | Prevention of Cyclophosphamide-Induced Immunosuppression in Mice with the Antimicrobial Peptide Sublancin. |
| Q97072736 | Re-evaluation of Quillaia extract (E 999) as a food additive and safety of the proposed extension of use |
| Q33459228 | SGLT1-mediated Transport in Caco-2 Cells Is Highly Dependent on Cell Bank Origin |
| Q77814773 | The "latent membrane permeability" concept: QSPR analysis of inter/intralaboratory variable Caco-2 permeability |
| Q40947744 | The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications |
| Q40618475 | The use of in vitro metabolic stability for rapid selection of compounds in early discovery based on their expected hepatic extraction ratios |
| Q36535786 | Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. |
Search more.